IDENTIFICATION OF ATTENUATING MUTATIONS IN THE DENGUE VIRUS GENOME
IDENTIFICATION OF ATTENUATING MUTATIONS IN THE DENGUE VIRUS GENOME
批准号:
3748171
负责人:
B FALGOUT
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
attenuated microorganism complementary DNA dengue virus endopeptidases gene mutation genome intracellular transport membrane structure nucleocapsid protein sequence protein signal sequence protein transport ubiquitin virulence virus RNA virus genetics virus infection mechanism virus protein virus replication
中文摘要
该项目的目标是识别非致命性突变,
登革病毒基因组,当其被整合到感染性cDNA中时,
克隆(项目编号Z 01 BK 07001-02)将降低毒力。(1)核
登革病毒衣壳(C)蛋白的定位。 法检测
羧基端存在核定位信号(NLS)
DEN4 C. 替代突变产生了
在40 aa结构域的可疑NLS内,
进行了评估。 只有一个突变体,其中所有(4)可能的NLS已被
在核运输中似乎发生了改变,这表明
黄病毒复制中的核依赖性步骤,
通过将选定的突变掺入感染性cDNA进行测试。(二)
登革病毒C. 这项工作已经完成。 膜
C的整合似乎稳定了分子对泛素的抵抗,
依赖性降解(手稿准备中)。 (3)膜集成
梭 黄病毒C含有一个保守的内部20-aa疏水区,
域 我们证明了这个域作为信号锚的功能
(SA)介导C. 此SA的功能是
对于有效识别prM信号肽至关重要,
在黄病毒多聚蛋白中紧邻C的下游。 (4)效果
DEN NS 2B蛋白突变对NS 3蛋白酶活性的影响。 到
进一步表征了NS 2B对蛋白酶活性的要求,
我们对病毒编码蛋白酶NS 3的NS 2B进行了40个氨基酸的结构域的诱变,
是蛋白酶活性不可缺少的。 分离出>60个突变体,并且
在体内和体外分析NS 2B-NS 3位点的自切割。
黄病毒NS 2B 40-aa结构域中5个保守氨基酸中的3个
是乳沟的必备条件 三个额外的半保守
还需要AAS。 一些突变导致了部分缺陷,
切割,从而确定引入
登革病毒基因组中的减毒突变(手稿在准备中)。 (五)
NS 1-NS 2A位点的切割。 已知这种分裂发生在
保守基序,其是ER驻留酶切割的共有位点
蛋白酶、信号肽酶(SP)。 然而,这一主题并没有出现在
信号肽的背景,识别信号肽的要求,
切割需要NS 1的羧基末端8个氨基酸,
NS 2A的氨基端70%。 今年我们展示了乳沟
在含有ER及其受体的微粒体存在下,
常驻蛋白酶。 可溶性管腔内酶的ER耗竭,
仍然具有切割活性,表明切割酶是ER
膜结合的 假设NS 1-NS 2A实体本身是一个
通过选择性诱变所有
可能需要在已知类型的活性位点,
蛋白酶 结果表明NS 1-NS 2A不是一种自身蛋白酶,
SP以一种新的方式催化NS 1-NS 2A裂解。
英文摘要
The goal of this project is the identification of nonlethal mutations in
the DEN virus genome which when incorporated into the infectious cDNA
clone (project# Z01 BK 07001-02) will reduce virulence. (1) Nuclear
localization of the dengue virus capsid (C) protein. We detected the
presence of a nuclear localization signal (NLS) in the carboxy-terminal
40 amino acids (aa) of the DEN4 C. Substitution mutations were created
within suspected NLSs in the 40 aa domain, and their nuclear transport
was assessed. Only a mutant in which all (4) possible NLSs had been
eliminated appeared to be altered in nuclear transport, suggesting
nucleus-dependent steps in the replication of flaviviruses which can be
tested by incorporation of selected mutations into infectious cDNA. (2)
Ubiquitination of the dengue virus C. This work was completed. Membrane
integration of C appeared to stabilize the molecule against ubiquitin-
dependent degradation (manuscript in prep). (3) Membrane integration
of C. The flavivirus C contains a conserved internal 20-aa hydrophobic
domain. We demonstrated that this domain functions as a signal-anchor
(SA) to mediate the membrane integration of C. Function of this SA is
essential for efficient recognition of the prM signal peptide, which lies
immediately downstream from C in the flavivirus polyprotein. (4) Effect
of mutations in the DEN NS2B protein on protease activity of NS3. To
further characterize the requirement of NS2B for the protease activity
of the virus-coded protease, NS3, we mutagenized a 40-aa domain in NS2B
indispensable for protease activity. >60 mutants were isolated, and
autocleavage at the NS2B-NS3 site was analyzed in vivo and in vitro.
Three of 5 aas conserved among flaviviruses in the 40-aa domain of NS2B
were absolutely required for cleavage. Three additional semi-conserved
aas were also required. Some mutations resulted in partial defects in
cleavage, thus defining potential sites for the introduction of
attenuating mutations into the dengue genome (manuscript in prep). (5)
Cleavage of the NS1-NS2A site. This cleavage is known to occur after a
conserved motif which is a consensus site for cleavage by the ER resident
protease, signal peptidase (SP). However, the motif does not occur in
the context of a signal peptide, a requirement for recognition of the
motif by SP. Cleavage requires the carboxy-terminal 8 aa of NS1 and the
amino-terminal 70%of NS2A. This year, we demonstrated that cleavage
takes place in vitro in the presence of microsomes containing ER and its
resident proteases. ER depleted of soluble intralumenal enzymes was
still active for cleavage, suggesting that the cleavage enzyme is ER
membrane-bound. The hypothesis that the NS1-NS2A entity is by itself an
autoprotease was investigated by selectively mutagenizing all aas that
could possibly be required at the active site of known types of
proteases. Results suggest that NS1-NS2A is not an autoprotease and that
NS1-NS2A cleavage is catalyzed by SP in a novel fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONSTRUCTION OF INFECTIOUS FULL LENGTH CDNA CLONE OF DEN
-
批准号:6545184
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
DENGUE VIRUS RNA REPLICATION
-
批准号:3792564
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
MUTAGENESIS OF THE DENGUE VIRUS PROTEASE
-
批准号:3792563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
IMMUNOGENICITY OF DENGUE TYPE 4 VIRUS NONSTRUCTURAL PROTEIN NS1
-
批准号:3822118
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:
Applications of infectious cDNA technology to RNA virus
-
批准号:6433528
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
IMMUNOGENICITY OF DENGUE TYPE 4 VIRUS NONSTRUCTURAL PROTEIN NS1
-
批准号:3809681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:
Applications of infectious cDNA technology to RNA virus
-
批准号:6678955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
DENGUE VACCINE DEVELOPMENT--MUTATIONS IN NONSTRUCTURAL PROTEIN REGION OF DEN2
-
批准号:6101203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
PRODUCTION OF ATTENUATED VACCINE CANDIDATE DENGUE VIRUSES FROM INFECTIOUS CDNA
-
批准号:3770341
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
IMMUNOGENICITY OF DENGUE TYPE 4 VIRUS NONSTRUCTURAL PROTEIN NS1
-
批准号:3818274
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:
APPLICATIONS OF INFECTIOUS CDNA TECHNOLOGY TO RNA VIRUS
-
批准号:6101208
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
DENGUE VACCINE DEVELOPMENT--MUTATIONS IN NONSTRUCTURAL PROTEIN REGION OF DEN2
-
批准号:6161266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
CONSTRUCTION OF INFECTIOUS FULL LENGTH CDNA CLONE OF DENGUE VIRUS TYPE 1
-
批准号:6161271
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
AN INFECTIOUS FULL LENGTH TRANSCRIPT OF DENGUE VIRUS TYPE 2
-
批准号:3792562
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
Infectious cDNA technology and RNA virus vaccines
-
批准号:6545182
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
Methods for evaluating attenuated vaccine candidate viru
-
批准号:6678948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
CONSTRUCTION OF INFECTIOUS FULL LENGTH CDNA CLONE OF DENGUE VIRUS TYPE 1
-
批准号:2456630
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
Methods for evaluating attenuated vaccine candidate viruses.
-
批准号:6433525
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
METHODS FOR EVALUATING ATTENUATED VACCINE CANDIDATE VIRUSES.
-
批准号:6293746
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
PRODUCTION OF ATTENUATED VACCINE CANDIDATE DENGUE VIRUSES FROM INFECTIOUS CDNA
-
批准号:3748170
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B FALGOUT
-
依托单位:--
海外基金